Yaffa
Yaffa Israell, Tel Aviv IL
Patent application number | Description | Published |
---|---|---|
20120018683 | CHARGE DIRECTOR FOR LIQUID TONER - A charge director material for charging a liquid toner, the charge director material comprising (a) nanoparticles of a simple salt and (b) a sulfosuccinate salt of the general formula MA | 01-26-2012 |
Yaffa Mizrachi-Nebenzahl, Beer Sheva IL
Patent application number | Description | Published |
---|---|---|
20090148470 | PROTEIN-BASED STREPTOCOCCUS PNEUMONIAE VACCINES - The present invention is primarily directed to a method for preventing infection of a mammalian subject with | 06-11-2009 |
20090186043 | Method and compositions for preventing and treating streptococcus pneumoniae infection - A method of preventing and/or treating | 07-23-2009 |
20090252756 | PROTEIN-BASED STREPTOCOCCUS PNEUMONIAE VACCINES - Vaccine compositions and methods for protecting a mammalian subject against infection with | 10-08-2009 |
20110236470 | GLUTAMYL tRNA SYNTHETASE (GtS) FRAGMENTS - The present invention relates to polypeptide fragments, including variants and analogs, of | 09-29-2011 |
20110305682 | Compositions and Methods for Treating S. Pneumonia Infection - The present invention relates to novel compounds that are useful for inhibition and prevention of pathogen cell adhesion and cell adhesion-mediated pathologies. This invention also relates to pharmaceutical formulations comprising these compounds and methods of using them for inhibition and prevention of pathogen cell adhesion and cell adhesion-mediated pathologies. The compounds and pharmaceutical compositions of this invention can be used as therapeutic or prophylactic agents. They are particularly well-suited for treatment of infectious diseases. | 12-15-2011 |
20120003203 | Compositions and Methods for Treating S. Pneumoniae Infection - The present invention relates to novel compounds that are useful for inhibition and prevention of pathogen cell adhesion and cell adhesion-mediated pathologies. This invention also relates to pharmaceutical formulations comprising these compounds and methods of using them for inhibition and prevention of pathogen cell adhesion and cell adhesion-mediated pathologies. The compounds and pharmaceutical compositions of this invention can be used as therapeutic or prophylactic agents. They are particularly well-suited for treatment of infectious diseases. | 01-05-2012 |
20120076813 | USES OF GLUTAMYL tRNA SYNTHETASE (GtS) FRAGMENTS - The present invention relates to polypeptide fragments, including variants and analogs, of | 03-29-2012 |
20120100172 | IMMUNOGENIC STREPTOCOCCUS PNEUMONIAE PEPTIDES AND PEPTIDE-MULTIMERS - The present invention relates to immunogenic peptides, including variants and analogs derived from | 04-26-2012 |
20130108659 | PROTEIN-BASED STREPTOCOCCUS PNEUMONIAE VACCINE | 05-02-2013 |
20140205623 | PROTEIN-BASED STREPTOCOCCUS PNEUMONIAE VACCINES - Vaccine compositions and methods for protecting a mammalian subject against infection with | 07-24-2014 |
20140212450 | PROTEIN-BASED STREPTOCOCCUS PNEUMONIAE VACCINES - Vaccine compositions and methods for protecting a mammalian subject against infection with | 07-31-2014 |